Keros Therapeutics, Inc. Profile Avatar - Palmy Investing

Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. T…

Biotechnology
US, Lexington [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of KROS's Analysis
CIK: 1664710 CUSIP: 492327101 ISIN: US4923271013 LEI: - UEI: -
Secondary Listings
KROS has no secondary listings inside our databases.